ERTAPENEM

ERTAPENEM was reported 7464 times

ERTAPENEM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 164 0.5413
1 AVIAN INFLUENZA 13 0.2031
2 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 2 0.1818
3 DURAL ABSCESS 2 0.1538
4 EPIDURAL CATHETER PLACEMENT 2 0.1538
5 ARTERIAL ANGIOPLASTY 3 0.1111
6 LEVATOR SYNDROME 4 0.1026
7 FEMALE GENITAL TRACT FISTULA 167 0.0977
8 UTERINE FISTULA 3 0.0909
9 RAOULTELLA ORNITHINOLYTICA INFECTION 7 0.0909
10 RENAL GRAFT INFECTION 17 0.0733
11 SUBDURAL ABSCESS 3 0.0652
12 MACULAR DEGENERATION 778 0.0651
13 RADICULOPATHY 164 0.0622
14 PROCTITIS 163 0.0581
15 CHRONIC SINUSITIS 215 0.0572
16 PROSTHETIC VALVE ENDOCARDITIS 3 0.0536
17 CHORIOCARCINOMA 4 0.0506
18 CITROBACTER SEPSIS 2 0.0500
19 AXONAL AND DEMYELINATING POLYNEUROPATHY 5 0.0490
20 GRANULOMATOUS DERMATITIS 11 0.0451
21 VITAMIN A DEFICIENCY 4 0.0392
22 URINARY TRACT INFLAMMATION 12 0.0333
23 MALACOPLAKIA 15 0.0328
24 CONDUCTIVE DEAFNESS 10 0.0312
25 BILIARY SEPSIS 14 0.0302
26 ENTEROCOLONIC FISTULA 4 0.0301
27 DISSEMINATED TRICHOSPORONOSIS 2 0.0278
28 DISSEMINATED VARICELLA ZOSTER VACCINE VIRUS INFECTION 2 0.0253
29 BURSA REMOVAL 2 0.0250
30 URINARY TRACT INFECTION PSEUDOMONAL 15 0.0250
31 RHODOCOCCUS INFECTION 4 0.0241
32 BURKHOLDERIA INFECTION 2 0.0241
33 OROPHARYNGEAL OEDEMA 3 0.0207
34 NORMOCHROMIC ANAEMIA 4 0.0200
35 PULMONARY AIR LEAKAGE 3 0.0199
36 PANCREATIC FISTULA 3 0.0195
37 EMPHYSEMATOUS CYSTITIS 4 0.0188
38 VITAMIN B1 DEFICIENCY 8 0.0187
39 MITOCHONDRIAL TOXICITY 14 0.0171
40 PLASMABLASTIC LYMPHOMA 6 0.0168
41 VAGINAL DISCHARGE 164 0.0162
42 GLOMERULONEPHROPATHY 4 0.0156
43 FACTOR V INHIBITION 3 0.0155
44 PLEURAL ADHESION 3 0.0150
45 CLOSTRIDIUM TEST POSITIVE 33 0.0150
46 PARAESTHESIA ORAL 214 0.0148
47 PROSTATIC ABSCESS 4 0.0145
48 COLONIC FISTULA 8 0.0141
49 HER2 POSITIVE BREAST CANCER 5 0.0133
50 HEPATIC INFARCTION 5 0.0133
51 BLOOD CREATININE 2 0.0131
52 ORAL CANDIDIASIS 171 0.0130
53 EOSINOPHILIC PNEUMONIA ACUTE 11 0.0127
54 CLOSTRIDIAL SEPSIS 3 0.0124
55 SPLENIC ABSCESS 5 0.0123
56 UREAPLASMA INFECTION 5 0.0123
57 VITAMIN B6 DEFICIENCY 3 0.0122
58 CYTOMEGALOVIRUS SYNDROME 2 0.0121
59 SERRATIA INFECTION 9 0.0121
60 INCISION SITE DISCHARGE 3 0.0119
61 ACUTE CARDIAC EVENT 2 0.0116
62 NEUROPSYCHOLOGICAL SYMPTOMS 7 0.0116
63 RHINOCEREBRAL MUCORMYCOSIS 4 0.0115
64 NEOVASCULARISATION 3 0.0114
65 PSEUDOPOLYP 4 0.0111
66 ESCHERICHIA TEST POSITIVE 13 0.0109
67 PSEUDOMONAL SEPSIS 19 0.0108
68 ACUTE PHASE REACTION 4 0.0105
69 NEUROMYOPATHY 11 0.0103
70 INFECTIVE ANEURYSM 5 0.0101
71 KLEBSIELLA BACTERAEMIA 9 0.0095
72 BLOOD STEM CELL TRANSPLANT FAILURE 2 0.0093
73 THERAPEUTIC PRODUCT CROSS-REACTIVITY 8 0.0090
74 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 2 0.0087
75 PATHOGEN RESISTANCE 79 0.0087
76 MAGNESIUM DEFICIENCY 4 0.0085
77 ANAPLASTIC LARGE-CELL LYMPHOMA 2 0.0085
78 DELAYED GRAFT FUNCTION 6 0.0084
79 CHOROIDITIS 3 0.0080
80 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
81 EXTRADURAL ABSCESS 6 0.0076
82 CLOSTRIDIUM DIFFICILE COLITIS 81 0.0076
83 COGWHEEL RIGIDITY 8 0.0076
84 RESPIRATORY TRACT INFECTION FUNGAL 4 0.0076
85 CHOLANGITIS INFECTIVE 2 0.0075
86 ANAL STENOSIS 4 0.0075
87 CORYNEBACTERIUM INFECTION 4 0.0075
88 ACINETOBACTER INFECTION 8 0.0073
89 TOXIC ENCEPHALOPATHY 37 0.0073
90 SEIZURE LIKE PHENOMENA 12 0.0071
91 BURKHOLDERIA CEPACIA COMPLEX INFECTION 2 0.0070
92 PROCEDURAL PAIN 194 0.0070
93 BREAST ABSCESS 7 0.0069
94 ENTEROCUTANEOUS FISTULA 6 0.0068
95 PERINEAL ABSCESS 3 0.0067
96 ENTEROBACTER BACTERAEMIA 2 0.0066
97 EYE ABSCESS 2 0.0066
98 ABDOMINAL COMPARTMENT SYNDROME 4 0.0063
99 HYPERCHLORAEMIA 4 0.0063
100 REFLEXES ABNORMAL 4 0.0062
101 CROSS SENSITIVITY REACTION 6 0.0062
102 FREQUENT BOWEL MOVEMENTS 166 0.0061
103 RENAL ABSCESS 5 0.0061
104 MYASTHENIA GRAVIS CRISIS 9 0.0061
105 METABOLIC ENCEPHALOPATHY 18 0.0060
106 KLEBSIELLA INFECTION 30 0.0059
107 HYPERTROPHIC CARDIOMYOPATHY 9 0.0058
108 WOUND SECRETION 22 0.0056
109 CATHETER REMOVAL 2 0.0056
110 ABSCESS BACTERIAL 2 0.0055
111 CLONIC CONVULSION 4 0.0055
112 PNEUMONIA KLEBSIELLA 10 0.0054
113 LINEAR IGA DISEASE 9 0.0054
114 INTERVERTEBRAL DISCITIS 10 0.0053
115 BLOODY DISCHARGE 6 0.0052
116 STENOTROPHOMONAS INFECTION 7 0.0052
117 ENCEPHALOPATHY 126 0.0051
118 ESCHERICHIA BACTERAEMIA 12 0.0051
119 CONVULSIVE THRESHOLD LOWERED 2 0.0051
120 INHIBITORY DRUG INTERACTION 8 0.0051
121 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2 0.0049
122 LEUKOCYTURIA 4 0.0049
123 SKIN ODOUR ABNORMAL 19 0.0048
124 POSTICTAL STATE 5 0.0048
125 FOOT AMPUTATION 7 0.0048
126 INCISION SITE COMPLICATION 4 0.0048
127 CANDIDA TEST POSITIVE 2 0.0048
128 ENTEROBACTER INFECTION 8 0.0048
129 TUMOUR NECROSIS 5 0.0047
130 ALVEOLAR OSTEITIS 2 0.0047
131 APPENDICITIS PERFORATED 12 0.0047
132 RESTING TREMOR 3 0.0046
133 COLITIS 171 0.0045
134 ADENOVIRUS INFECTION 13 0.0045
135 EOSINOPHILIC PNEUMONIA 14 0.0044
136 CORONARY ANGIOPLASTY 2 0.0044
137 DISORGANISED SPEECH 8 0.0043
138 RASH MORBILLIFORM 12 0.0043
139 LIVER ABSCESS 14 0.0043
140 FUSARIUM INFECTION 3 0.0043
141 ECZEMA ASTEATOTIC 2 0.0042
142 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
143 ANTIBODY TEST ABNORMAL 3 0.0042
144 HIDRADENITIS 38 0.0042
145 NEUROTOXICITY 73 0.0042
146 CARDIAC VALVE VEGETATION 2 0.0041
147 AMPUTATION 5 0.0040
148 HEPATITIS CHOLESTATIC 24 0.0040
149 CHOLANGITIS ACUTE 3 0.0040
150 REDUCED FACIAL EXPRESSION 4 0.0039
151 ESCHERICHIA INFECTION 32 0.0039
152 RECTAL HAEMORRHAGE 167 0.0039
153 MUSCLE DISCOMFORT 3 0.0038
154 FUNGAEMIA 6 0.0038
155 ENTEROCOCCAL BACTERAEMIA 4 0.0038
156 HERPES ZOSTER DISSEMINATED 3 0.0037
157 EXCESSIVE GRANULATION TISSUE 3 0.0037
158 COLITIS ULCERATIVE 166 0.0037
159 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
160 CIRCADIAN RHYTHM SLEEP DISORDER 3 0.0036
161 CLOSTRIDIUM DIFFICILE INFECTION 79 0.0036
162 SERUM SICKNESS 10 0.0036
163 PSEUDOMEMBRANOUS COLITIS 8 0.0036
164 BODY TINEA 2 0.0036
165 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
166 CARDIORENAL SYNDROME 2 0.0035
167 FOLATE DEFICIENCY 4 0.0035
168 ABSCESS DRAINAGE 3 0.0035
169 RENAL INFARCT 5 0.0035
170 PULMONARY CAVITATION 3 0.0034
171 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 2 0.0034
172 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
173 MIXED LIVER INJURY 10 0.0033
174 DRUG RESISTANCE 85 0.0033
175 PRODUCT PACKAGING CONFUSION 8 0.0033
176 SOFT TISSUE INFECTION 6 0.0033
177 STATUS EPILEPTICUS 37 0.0033
178 VESTIBULAR DISORDER 4 0.0033
179 PNEUMONIA PSEUDOMONAL 5 0.0033
180 OTOTOXICITY 6 0.0032
181 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 25 0.0032
182 INFUSION RELATED REACTION 213 0.0032
183 ENDOTRACHEAL INTUBATION 9 0.0032
184 NOSOCOMIAL INFECTION 7 0.0032
185 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 223 0.0031
186 ACTINOMYCOSIS 3 0.0031
187 BILIARY OBSTRUCTION 4 0.0031
188 HAEMATOCHEZIA 170 0.0031
189 TONIC CLONIC MOVEMENTS 4 0.0031
190 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
191 MYOCLONUS 36 0.0030
192 BONE DEFORMITY 2 0.0030
193 ABDOMINAL ABSCESS 13 0.0029
194 INTESTINAL MASS 4 0.0029
195 TOXOPLASMOSIS 3 0.0028
196 ESCHAR 2 0.0027
197 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
198 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 70 0.0027
199 COMA HEPATIC 2 0.0027
200 BACTERIAL TEST POSITIVE 6 0.0027
201 LICHENOID KERATOSIS 6 0.0026
202 DEBRIDEMENT 2 0.0026
203 HYPERREFLEXIA 9 0.0026
204 MULTIPLE-DRUG RESISTANCE 8 0.0026
205 NECROTISING FASCIITIS 9 0.0026
206 GROIN ABSCESS 3 0.0025
207 OSTEOSCLEROSIS 4 0.0025
208 ENDOCARDITIS 13 0.0025
209 DEVICE RELATED SEPSIS 5 0.0025
210 ENTEROCOCCAL INFECTION 12 0.0025
211 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
212 GLOMERULONEPHRITIS 6 0.0024
213 DYSBIOSIS 2 0.0024
214 CAMPYLOBACTER INFECTION 2 0.0024
215 CULTURE POSITIVE 2 0.0024
216 POSTOPERATIVE WOUND COMPLICATION 3 0.0024
217 ABDOMINAL INFECTION 6 0.0023
218 EOSINOPHILIA 41 0.0023
219 NEPHROPATHY TOXIC 26 0.0023
220 SPLENIC INFARCTION 4 0.0023
221 UROSEPSIS 21 0.0023
222 HALLUCINATION, VISUAL 48 0.0023
223 BLOOD ALBUMIN INCREASED 2 0.0022
224 TRANSPLANT DYSFUNCTION 4 0.0022
225 PYODERMA GANGRENOSUM 8 0.0022
226 ANAEMIA OF CHRONIC DISEASE 2 0.0022
227 VASCULAR DEVICE INFECTION 10 0.0022
228 DRUG LEVEL BELOW THERAPEUTIC 12 0.0022
229 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
230 LUNG CONSOLIDATION 6 0.0021
231 CEREBRAL TOXOPLASMOSIS 2 0.0021
232 RENAL TUBULAR NECROSIS 21 0.0021
233 HALLUCINATIONS, MIXED 9 0.0021
234 RENAL TUBULAR DISORDER 6 0.0021
235 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
236 TONIC CONVULSION 3 0.0021
237 HUMAN HERPESVIRUS 6 INFECTION 4 0.0021
238 ABSCESS LIMB 9 0.0021
239 TRACHEOSTOMY 3 0.0021
240 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
241 POST HERPETIC NEURALGIA 3 0.0021
242 ESCHERICHIA SEPSIS 6 0.0021
243 EPILEPSY 63 0.0021
244 ANIMAL SCRATCH 2 0.0021
245 MENTAL STATUS CHANGES 57 0.0021
246 WOUND COMPLICATION 7 0.0020
247 HEART VALVE REPLACEMENT 3 0.0020
248 ANORECTAL DISORDER 4 0.0020
249 DYSPEPSIA 197 0.0020
250 BLOOD IMMUNOGLOBULIN M DECREASED 2 0.0020
251 URINARY TRACT INFECTION BACTERIAL 5 0.0020
252 INFECTIOUS PLEURAL EFFUSION 3 0.0020
253 SKIN INDURATION 4 0.0019
254 MEGACOLON 3 0.0019
255 LUNG ABSCESS 4 0.0019
256 EXFOLIATIVE RASH 5 0.0019
257 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
258 AREFLEXIA 5 0.0019
259 CLONUS 5 0.0018
260 ERYTHEMA MULTIFORME 17 0.0018
261 HYPERAMMONAEMIA 9 0.0018
262 SEROTONIN SYNDROME 34 0.0018
263 SLEEP TALKING 3 0.0018
264 AZOTAEMIA 7 0.0018
265 CARBON DIOXIDE DECREASED 2 0.0017
266 PYELONEPHRITIS 15 0.0017
267 NEUROLOGICAL DECOMPENSATION 4 0.0017
268 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 4 0.0017
269 EPIDIDYMITIS 2 0.0017
270 ARTHRITIS BACTERIAL 7 0.0017
271 TOOTH DISCOLOURATION 5 0.0017
272 NYSTAGMUS 9 0.0017
273 DRUG LEVEL INCREASED 28 0.0017
274 BONE MARROW TOXICITY 2 0.0017
275 JUGULAR VEIN THROMBOSIS 3 0.0017
276 PSEUDOMONAS INFECTION 14 0.0016
277 COAGULOPATHY 27 0.0016
278 BLADDER DISCOMFORT 2 0.0016
279 HYPERNATRAEMIA 8 0.0016
280 BACTERAEMIA 19 0.0016
281 HYPERPARATHYROIDISM SECONDARY 4 0.0016
282 DELIRIUM 55 0.0016
283 ADENOCARCINOMA PANCREAS 2 0.0016
284 URINARY TRACT DISORDER 7 0.0016
285 HEPATITIS ACUTE 10 0.0015
286 HEPATITIS TOXIC 4 0.0015
287 BICYTOPENIA 3 0.0015
288 COLOSTOMY 3 0.0015
289 MALNUTRITION 17 0.0015
290 BONE MARROW FAILURE 30 0.0015
291 SUBARACHNOID HAEMORRHAGE 15 0.0015
292 METABOLIC ACIDOSIS 47 0.0015
293 CLUMSINESS 4 0.0015
294 SCAR 25 0.0015
295 AUTOIMMUNE HAEMOLYTIC ANAEMIA 5 0.0015
296 ENCEPHALITIS 10 0.0014
297 HAEMODYNAMIC INSTABILITY 11 0.0014
298 CHOLECYSTITIS INFECTIVE 4 0.0014
299 HEPATOCELLULAR INJURY 20 0.0014
300 NEUROLOGICAL SYMPTOM 8 0.0014
301 ABSCESS INTESTINAL 3 0.0014
302 EXPOSED BONE IN JAW 3 0.0014
303 MUSCLE SPASTICITY 17 0.0014
304 HALLUCINATION 103 0.0014
305 TRISMUS 7 0.0014
306 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
307 CHOLANGIOCARCINOMA 2 0.0013
308 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
309 OSTEOMYELITIS 24 0.0013
310 THERAPEUTIC PRODUCT EFFECT DELAYED 6 0.0013
311 PROSTATITIS 4 0.0013
312 HYPOALBUMINAEMIA 10 0.0013
313 BLOOD CREATININE DECREASED 4 0.0013
314 NECROSIS 7 0.0013
315 LACUNAR INFARCTION 3 0.0013
316 CONFUSIONAL STATE 198 0.0012
317 HYPOPHOSPHATAEMIA 9 0.0012
318 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
319 SEPTIC SHOCK 52 0.0012
320 SYSTEMIC CANDIDA 3 0.0012
321 ANAEMIA 226 0.0012
322 DRUG-INDUCED LIVER INJURY 37 0.0012
323 ILEOSTOMY 3 0.0012
324 BLADDER NEOPLASM 2 0.0012
325 FISTULA 13 0.0012
326 MUCORMYCOSIS 3 0.0012
327 EXTREMITY NECROSIS 2 0.0011
328 LUNG OPACITY 3 0.0011
329 LYMPHOPENIA 16 0.0011
330 ANAL FISTULA 6 0.0011
331 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
332 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
333 ABDOMINAL RIGIDITY 3 0.0011
334 LEUKOCYTOSIS 20 0.0011
335 DEVICE RELATED INFECTION 17 0.0011
336 STREPTOCOCCAL INFECTION 6 0.0011
337 HYPOMAGNESAEMIA 15 0.0011
338 LEUKOENCEPHALOPATHY 4 0.0011
339 ANGIOPATHY 6 0.0011
340 ADENOCARCINOMA OF COLON 2 0.0011
341 ASPERGILLUS INFECTION 7 0.0011
342 PYREXIA 369 0.0011
343 HYPERBILIRUBINAEMIA 11 0.0011
344 SMALL INTESTINAL OBSTRUCTION 13 0.0011
345 KIDNEY TRANSPLANT REJECTION 5 0.0010
346 ARTERIAL THROMBOSIS 2 0.0010
347 PRODUCT LABEL CONFUSION 6 0.0010
348 VITAMIN D DEFICIENCY 10 0.0010
349 SEIZURE 118 0.0010
350 VENOUS THROMBOSIS 4 0.0010
351 STAPHYLOCOCCAL SEPSIS 5 0.0010
352 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
353 CENTRAL VENOUS CATHETERISATION 3 0.0010
354 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
355 SKIN LESION 27 0.0010
356 DIABETIC FOOT 3 0.0010
357 DIVERTICULAR PERFORATION 2 0.0010
358 SEPSIS 108 0.0010
359 FAILURE TO THRIVE 5 0.0010
360 BLOOD BILIRUBIN INCREASED 26 0.0010
361 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
362 BODY TEMPERATURE FLUCTUATION 2 0.0010
363 DYSARTHRIA 36 0.0010
364 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
365 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
366 FAECAL CALPROTECTIN INCREASED 3 0.0009
367 BILE DUCT STONE 3 0.0009
368 FOETAL DISTRESS SYNDROME 2 0.0009
369 RESPIRATORY DISTRESS 26 0.0009
370 HYDRONEPHROSIS 7 0.0009
371 EXOPHTHALMOS 2 0.0009
372 BACTERIAL SEPSIS 3 0.0009
373 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
374 BACTERIAL INFECTION 17 0.0009
375 INTESTINAL ISCHAEMIA 5 0.0009
376 ABDOMINAL PAIN 210 0.0009
377 WEIGHT DECREASED 251 0.0009
378 RASH MACULO-PAPULAR 20 0.0009
379 HAEMOLYTIC ANAEMIA 8 0.0009
380 MENINGITIS ASEPTIC 4 0.0009
381 CYST 11 0.0009
382 PAPILLOEDEMA 4 0.0009
383 HAEMOGLOBIN INCREASED 4 0.0009
384 ERYTHEMA 180 0.0009
385 LYMPHOEDEMA 6 0.0009
386 BLOOD CREATININE ABNORMAL 3 0.0009
387 LACTIC ACIDOSIS 28 0.0009
388 RHABDOMYOLYSIS 36 0.0009
389 HYPERTRANSAMINASAEMIA 6 0.0009
390 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
391 CONSTIPATION 188 0.0009
392 JAUNDICE CHOLESTATIC 3 0.0008
393 DRUG INTERACTION 133 0.0008
394 HYPOVOLAEMIC SHOCK 4 0.0008
395 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
396 THERAPY PARTIAL RESPONDER 13 0.0008
397 BONE LESION 3 0.0008
398 MONOCYTE COUNT INCREASED 3 0.0008
399 THROMBOCYTOSIS 3 0.0008
400 NASAL POLYPS 4 0.0008
401 HYPERVOLAEMIA 4 0.0008
402 ACUTE PSYCHOSIS 2 0.0008
403 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
404 TENDON INJURY 3 0.0008
405 CHOLANGITIS 5 0.0008
406 CYTOKINE RELEASE SYNDROME 16 0.0008
407 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
408 HYPOCALCAEMIA 15 0.0008
409 DRUG INEFFECTIVE 1032 0.0008
410 HEPATITIS 20 0.0008
411 BLOOD CHLORIDE DECREASED 2 0.0008
412 UNRESPONSIVE TO STIMULI 20 0.0008
413 SKIN NECROSIS 4 0.0008
414 STEVENS-JOHNSON SYNDROME 17 0.0008
415 PARTIAL SEIZURES 4 0.0008
416 THROMBOCYTOPENIA 85 0.0008
417 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
418 PANCREATITIS ACUTE 17 0.0008
419 ABSCESS 12 0.0008
420 MULTI-ORGAN FAILURE 13 0.0008
421 BLOOD POTASSIUM ABNORMAL 2 0.0007
422 MENINGITIS 5 0.0007
423 EAR CONGESTION 2 0.0007
424 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
425 JAW DISORDER 4 0.0007
426 ACUTE RESPIRATORY FAILURE 14 0.0007
427 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
428 CYTOMEGALOVIRUS INFECTION 12 0.0007
429 EOSINOPHIL COUNT INCREASED 6 0.0007
430 PANCREATITIS 38 0.0007
431 INTESTINAL PERFORATION 8 0.0007
432 HEPATOMEGALY 7 0.0007
433 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
434 HYPERPYREXIA 3 0.0007
435 NEUTROPENIA 96 0.0007
436 PURULENT DISCHARGE 3 0.0007
437 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
438 TREATMENT FAILURE 58 0.0007
439 DUODENAL ULCER HAEMORRHAGE 2 0.0007
440 HYPERTONIA 4 0.0007
441 STAPHYLOCOCCAL INFECTION 23 0.0007
442 ACUTE KIDNEY INJURY 106 0.0007
443 COMA SCALE ABNORMAL 2 0.0007
444 NODULE 9 0.0007
445 DRUG LEVEL DECREASED 7 0.0007
446 RASH PUSTULAR 5 0.0007
447 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
448 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
449 PHYSICAL DISABILITY 3 0.0007
450 ILEUS PARALYTIC 3 0.0007
451 BLOOD CULTURE POSITIVE 2 0.0007
452 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
453 DISORIENTATION 26 0.0007
454 HYPOXIA 23 0.0007
455 ISCHAEMIA 3 0.0007
456 CHEST X-RAY ABNORMAL 2 0.0007
457 FIBROSIS 2 0.0006
458 DIASTOLIC DYSFUNCTION 2 0.0006
459 ARTHRITIS INFECTIVE 3 0.0006
460 ASPIRATION 7 0.0006
461 SKIN ABRASION 3 0.0006
462 BLADDER PAIN 2 0.0006
463 TRANSPLANT REJECTION 5 0.0006
464 DYSTONIA 12 0.0006
465 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
466 DECUBITUS ULCER 5 0.0006
467 ABNORMAL FAECES 5 0.0006
468 INFLAMMATORY MARKER INCREASED 3 0.0006
469 POST-TRAUMATIC STRESS DISORDER 4 0.0006
470 CORONARY ARTERY STENOSIS 3 0.0006
471 TOXIC SKIN ERUPTION 6 0.0006
472 BRONCHIECTASIS 4 0.0006
473 PRODUCT USE IN UNAPPROVED INDICATION 147 0.0006
474 CANDIDA INFECTION 10 0.0006
475 CLOSTRIDIAL INFECTION 2 0.0006
476 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
477 B-CELL LYMPHOMA 2 0.0006
478 PETIT MAL EPILEPSY 3 0.0006
479 CEREBRAL HAEMORRHAGE 21 0.0006
480 NEUTROPHIL COUNT INCREASED 6 0.0006
481 PHLEBITIS 3 0.0006
482 HYPOKALAEMIA 27 0.0006
483 PERIPHERAL VASCULAR DISORDER 3 0.0006
484 BLOOD MAGNESIUM DECREASED 5 0.0006
485 HYPOGLYCAEMIA 28 0.0006
486 LARGE INTESTINE PERFORATION 4 0.0006
487 FUNGAL INFECTION 19 0.0006
488 EMBOLIC STROKE 2 0.0006
489 IMMUNOSUPPRESSION 5 0.0006
490 HALLUCINATION, AUDITORY 9 0.0006
491 LUNG INFILTRATION 5 0.0006
492 GENERALISED OEDEMA 7 0.0006
493 SHOCK 13 0.0006
494 DRUG ERUPTION 10 0.0006
495 FIBRIN D DIMER INCREASED 2 0.0006
496 ANAL ABSCESS 3 0.0006
497 ANAL INCONTINENCE 5 0.0006
498 HEPATIC CYTOLYSIS 7 0.0005
499 END STAGE RENAL DISEASE 10 0.0005
500 HYPERKERATOSIS 3 0.0005
501 HYPERKALAEMIA 19 0.0005
502 GRAND MAL CONVULSION 5 0.0005
503 HEPATOTOXICITY 12 0.0005
504 HEPATIC ENCEPHALOPATHY 5 0.0005
505 BLOOD CALCIUM DECREASED 6 0.0005
506 MALAISE 233 0.0005
507 AGITATION 39 0.0005
508 HEPATIC FAILURE 16 0.0005
509 LIVER INJURY 13 0.0005
510 CHOLECYSTITIS ACUTE 3 0.0005
511 CATHETER SITE INFECTION 2 0.0005
512 NEUTROPHILIA 3 0.0005
513 HAEMATOTOXICITY 5 0.0005
514 GASTRIC ULCER 10 0.0005
515 DERMATITIS CONTACT 6 0.0005
516 RESPIRATORY FAILURE 38 0.0005
517 RALES 3 0.0005
518 ELECTROLYTE IMBALANCE 6 0.0005
519 URINARY TRACT INFECTION 88 0.0005
520 APNOEA 4 0.0005
521 PARKINSONISM 5 0.0005
522 SPLENOMEGALY 6 0.0005
523 DECREASED INTEREST 3 0.0005
524 CONVULSION 29 0.0005
525 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
526 BLOOD CREATININE INCREASED 33 0.0005
527 CHOLECYSTITIS 6 0.0005
528 TRICUSPID VALVE INCOMPETENCE 4 0.0005
529 CEREBRAL ATROPHY 2 0.0005
530 MUSCLE RIGIDITY 6 0.0005
531 CANDIDIASIS 2 0.0005
532 GANGRENE 3 0.0005
533 LOCALISED INFECTION 12 0.0005
534 PLEURAL EFFUSION 30 0.0005
535 SHOCK HAEMORRHAGIC 4 0.0005
536 RASH PAPULAR 11 0.0005
537 RASH ERYTHEMATOUS 23 0.0005
538 OFF LABEL USE 421 0.0005
539 LEUKOPENIA 24 0.0005
540 HAEMODIALYSIS 4 0.0005
541 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
542 PROTEINURIA 9 0.0005
543 MOBILITY DECREASED 34 0.0005
544 PAIN 290 0.0005
545 RENAL PAIN 5 0.0005
546 CHOLESTASIS 9 0.0005
547 FEBRILE NEUTROPENIA 31 0.0005
548 OCCUPATIONAL EXPOSURE TO PRODUCT 3 0.0005
549 PROCTALGIA 3 0.0005
550 INCOHERENT 3 0.0005
551 MYOPATHY 4 0.0005
552 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
553 HERPES SIMPLEX 3 0.0005
554 BRADYPHRENIA 3 0.0005
555 PRODUCT PRESCRIBING ISSUE 10 0.0005
556 HYPOGAMMAGLOBULINAEMIA 3 0.0005
557 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
558 RENAL FAILURE ACUTE 19 0.0004
559 QUALITY OF LIFE DECREASED 6 0.0004
560 THERAPY NON-RESPONDER 20 0.0004
561 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
562 PNEUMOTHORAX 7 0.0004
563 TACHYPNOEA 6 0.0004
564 DISEASE COMPLICATION 2 0.0004
565 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
566 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
567 JOINT EFFUSION 3 0.0004
568 ANGIOEDEMA 19 0.0004
569 PANCYTOPENIA 24 0.0004
570 FLANK PAIN 4 0.0004
571 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
572 HYPOTENSION 85 0.0004
573 THERMAL BURN 3 0.0004
574 SINUS TACHYCARDIA 6 0.0004
575 LIVER FUNCTION TEST INCREASED 9 0.0004
576 GAIT INABILITY 14 0.0004
577 BLOOD UREA INCREASED 7 0.0004
578 ATELECTASIS 4 0.0004
579 MENTAL DISORDER 18 0.0004
580 FAECES SOFT 3 0.0004
581 THERAPY CHANGE 4 0.0004
582 CARDIOMEGALY 5 0.0004
583 BODY TEMPERATURE DECREASED 4 0.0004
584 LIMB INJURY 11 0.0004
585 RENAL IMPAIRMENT 34 0.0004
586 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
587 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
588 LYMPHOCYTE COUNT DECREASED 7 0.0004
589 TROPONIN INCREASED 3 0.0004
590 HYPERTHERMIA 3 0.0004
591 PERITONITIS 8 0.0004
592 PULMONARY HAEMORRHAGE 3 0.0004
593 PETECHIAE 4 0.0004
594 NAUSEA 302 0.0004
595 DYSURIA 14 0.0004
596 MOUTH ULCERATION 8 0.0004
597 LIVER FUNCTION TEST ABNORMAL 11 0.0004
598 BLOOD ALBUMIN DECREASED 3 0.0004
599 RENAL CYST 3 0.0004
600 LOW BIRTH WEIGHT BABY 3 0.0004
601 CELLULITIS 19 0.0004
602 COMPRESSION FRACTURE 2 0.0004
603 INFECTION 53 0.0004
604 ACUTE HEPATIC FAILURE 5 0.0004
605 CARDIAC ARREST 30 0.0004
606 DIVERTICULITIS 10 0.0004
607 PNEUMONIA ASPIRATION 9 0.0004
608 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
609 MASS 5 0.0004
610 RENAL FAILURE 47 0.0004
611 CHILLS 41 0.0003
612 MYOCARDITIS 4 0.0003
613 ENTEROCOLITIS 2 0.0003
614 HYPOKINESIA 5 0.0003
615 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
616 URINE OUTPUT DECREASED 3 0.0003
617 TUMOUR LYSIS SYNDROME 3 0.0003
618 BRADYCARDIA 18 0.0003
619 PURPURA 3 0.0003
620 ATRIAL FIBRILLATION 33 0.0003
621 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
622 TACHYCARDIA 30 0.0003
623 ATAXIA 4 0.0003
624 WRIST FRACTURE 4 0.0003
625 ADRENAL INSUFFICIENCY 4 0.0003
626 PNEUMONIA BACTERIAL 3 0.0003
627 CONDITION AGGRAVATED 99 0.0003
628 DEFORMITY 3 0.0003
629 TARDIVE DYSKINESIA 9 0.0003
630 ARTERIOSCLEROSIS 3 0.0003
631 BRAIN OEDEMA 4 0.0003
632 COMA 15 0.0003
633 PREMATURE DELIVERY 5 0.0003
634 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
635 ORAL HERPES 6 0.0003
636 MANIA 5 0.0003
637 HEADACHE 190 0.0003
638 PHOTOSENSITIVITY REACTION 5 0.0003
639 HAEMATOCRIT DECREASED 6 0.0003
640 CORONAVIRUS INFECTION 2 0.0003
641 TOXICITY TO VARIOUS AGENTS 51 0.0003
642 C-REACTIVE PROTEIN INCREASED 11 0.0003
643 SOPOR 4 0.0003
644 BREAST MASS 2 0.0003
645 PERITONITIS BACTERIAL 3 0.0003
646 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
647 EYELID PTOSIS 3 0.0003
648 SLUGGISHNESS 3 0.0003
649 EYE MOVEMENT DISORDER 2 0.0003
650 ECCHYMOSIS 2 0.0003
651 RIB FRACTURE 6 0.0003
652 DRUG INTOLERANCE 28 0.0003
653 NERVOUS SYSTEM DISORDER 9 0.0003
654 CARDIAC FAILURE 23 0.0003
655 TRANSFUSION 3 0.0003
656 WOUND 8 0.0003
657 INCONTINENCE 3 0.0003
658 BLINDNESS UNILATERAL 4 0.0003
659 GOUT 5 0.0003
660 COGNITIVE DISORDER 13 0.0003
661 DECREASED ACTIVITY 3 0.0003
662 MYELOSUPPRESSION 10 0.0003
663 ABDOMINAL PAIN LOWER 7 0.0003
664 FAECES DISCOLOURED 6 0.0003
665 CHRONIC KIDNEY DISEASE 21 0.0003
666 HYPOPHAGIA 7 0.0003
667 DISEASE RECURRENCE 13 0.0003
668 MUSCULAR WEAKNESS 31 0.0003
669 ASCITES 8 0.0003
670 INFLAMMATION 14 0.0003
671 DYSKINESIA 11 0.0003
672 URINARY INCONTINENCE 8 0.0003
673 TRANSAMINASES INCREASED 6 0.0003
674 URINARY RETENTION 9 0.0003
675 AGRANULOCYTOSIS 5 0.0003
676 SEDATION 7 0.0003
677 ANHEDONIA 7 0.0003
678 REBOUND EFFECT 3 0.0003
679 HYPOAESTHESIA ORAL 4 0.0003
680 INTESTINAL OBSTRUCTION 10 0.0003
681 MITRAL VALVE INCOMPETENCE 3 0.0003
682 ECONOMIC PROBLEM 4 0.0003
683 BLOOD URINE PRESENT 5 0.0003
684 NEUROPATHY PERIPHERAL 25 0.0003
685 SUICIDAL IDEATION 24 0.0003
686 PNEUMONIA 84 0.0003
687 LIMB DISCOMFORT 8 0.0003
688 OEDEMA 14 0.0003
689 APHTHOUS ULCER 2 0.0003
690 DELUSION 4 0.0003
691 PALLOR 7 0.0003
692 ACUTE MYELOID LEUKAEMIA 4 0.0003
693 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
694 HEART RATE DECREASED 9 0.0003
695 KIDNEY INFECTION 5 0.0003
696 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
697 BLISTER 14 0.0002
698 TREMOR 41 0.0002
699 HYPERGLYCAEMIA 9 0.0002
700 BLOOD POTASSIUM INCREASED 4 0.0002
701 NO THERAPEUTIC RESPONSE 3 0.0002
702 RESTLESSNESS 9 0.0002
703 BODY TEMPERATURE INCREASED 5 0.0002
704 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
705 CHOLELITHIASIS 8 0.0002
706 HAEMOGLOBIN DECREASED 25 0.0002
707 LETHARGY 14 0.0002
708 OSTEONECROSIS OF JAW 6 0.0002
709 VENTRICULAR TACHYCARDIA 4 0.0002
710 ILEUS 3 0.0002
711 EPISTAXIS 18 0.0002
712 NEPHROLITHIASIS 11 0.0002
713 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
714 HEMIPARESIS 4 0.0002
715 RENAL INJURY 7 0.0002
716 EATING DISORDER 5 0.0002
717 HAEMATURIA 8 0.0002
718 ROTATOR CUFF SYNDROME 3 0.0002
719 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
720 BLOOD POTASSIUM DECREASED 7 0.0002
721 MUSCULOSKELETAL DISCOMFORT 4 0.0002
722 RASH GENERALISED 6 0.0002
723 SPEECH DISORDER 12 0.0002
724 MELAENA 5 0.0002
725 PLATELET COUNT DECREASED 24 0.0002
726 JAUNDICE 6 0.0002
727 DYSPHAGIA 21 0.0002
728 RESPIRATORY ARREST 6 0.0002
729 HIP FRACTURE 7 0.0002
730 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
731 MUSCLE TWITCHING 5 0.0002
732 ORAL DISCOMFORT 3 0.0002
733 COORDINATION ABNORMAL 3 0.0002
734 DEMENTIA 6 0.0002
735 HEPATIC FUNCTION ABNORMAL 8 0.0002
736 HYPONATRAEMIA 12 0.0002
737 HEPATIC CIRRHOSIS 4 0.0002
738 PRODUCT USE ISSUE 40 0.0002
739 DIALYSIS 3 0.0002
740 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
741 CARDIOGENIC SHOCK 3 0.0002
742 BLOOD PRESSURE FLUCTUATION 5 0.0002
743 DECREASED APPETITE 48 0.0002
744 MENTAL IMPAIRMENT 5 0.0002
745 EAR PAIN 4 0.0002
746 HEPATIC ENZYME INCREASED 14 0.0002
747 SINUSITIS 21 0.0002
748 ACUTE MYOCARDIAL INFARCTION 6 0.0002
749 PSYCHOTIC DISORDER 6 0.0002
750 SINUS DISORDER 4 0.0002
751 BLADDER DISORDER 2 0.0002
752 PULMONARY MASS 3 0.0002
753 IMMUNODEFICIENCY 3 0.0002
754 SWELLING FACE 13 0.0002
755 ANAPHYLACTIC REACTION 11 0.0002
756 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
757 EMPHYSEMA 2 0.0002
758 EAR DISCOMFORT 2 0.0002
759 PRODUCT PREPARATION ERROR 4 0.0002
760 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
761 LYMPHOMA 3 0.0002
762 SKIN ULCER 5 0.0002
763 EJECTION FRACTION DECREASED 3 0.0002
764 HAEMATOMA 5 0.0002
765 TOOTH LOSS 4 0.0002
766 ABDOMINAL DISTENSION 20 0.0002
767 MUCOSAL INFLAMMATION 5 0.0002
768 CYANOSIS 3 0.0002
769 DIARRHOEA 123 0.0002
770 SOMNOLENCE 38 0.0002
771 HYPOTHYROIDISM 6 0.0002
772 POOR QUALITY SLEEP 4 0.0002
773 INJURY 13 0.0002
774 THROAT TIGHTNESS 5 0.0002
775 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
776 IMPAIRED HEALING 6 0.0002
777 BLOOD PRESSURE DECREASED 12 0.0002
778 VERTIGO 11 0.0002
779 AGGRESSION 9 0.0002
780 HAEMOPTYSIS 5 0.0002
781 FALL 59 0.0002
782 HEART RATE IRREGULAR 4 0.0002
783 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
784 CHOLECYSTECTOMY 2 0.0002
785 URTICARIA 29 0.0002
786 EYELID OEDEMA 2 0.0002
787 RASH 75 0.0002
788 DYSSTASIA 5 0.0002
789 METASTASES TO LIVER 3 0.0002
790 COVID-19 PNEUMONIA 2 0.0002
791 ARRHYTHMIA 8 0.0002
792 BLOOD IRON DECREASED 2 0.0002
793 PRODUCT PRESCRIBING ERROR 4 0.0002
794 GASTROINTESTINAL DISORDER 15 0.0002
795 RESPIRATORY DISORDER 5 0.0002
796 MYALGIA 28 0.0002
797 OEDEMA PERIPHERAL 20 0.0002
798 CYTOPENIA 2 0.0002
799 HAEMORRHAGE 17 0.0002
800 BRONCHITIS 12 0.0002
801 HEPATIC STEATOSIS 3 0.0002
802 OXYGEN SATURATION DECREASED 9 0.0002
803 SLEEP APNOEA SYNDROME 3 0.0002
804 CYSTITIS 5 0.0002
805 POST PROCEDURAL COMPLICATION 3 0.0002
806 THERAPY CESSATION 8 0.0002
807 NIGHT SWEATS 5 0.0002
808 ASTHENIA 58 0.0002
809 DEEP VEIN THROMBOSIS 10 0.0002
810 BEDRIDDEN 2 0.0002
811 ANKYLOSING SPONDYLITIS 2 0.0002
812 UPPER LIMB FRACTURE 3 0.0002
813 DEHYDRATION 20 0.0001
814 RASH PRURITIC 8 0.0001
815 NEUTROPHIL COUNT DECREASED 6 0.0001
816 DRUG TOXICITY 2 0.0001
817 PRODUCTIVE COUGH 7 0.0001
818 HYPERTENSION 31 0.0001
819 CARDIO-RESPIRATORY ARREST 6 0.0001
820 DERMATITIS 3 0.0001
821 RASH MACULAR 5 0.0001
822 WITHDRAWAL SYNDROME 6 0.0001
823 BLOOD TEST ABNORMAL 2 0.0001
824 PAIN IN JAW 4 0.0001
825 FLATULENCE 8 0.0001
826 JOINT INJURY 3 0.0001
827 RED BLOOD CELL COUNT DECREASED 4 0.0001
828 BALANCE DISORDER 12 0.0001
829 PRODUCT DISPENSING ERROR 3 0.0001
830 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
831 PULMONARY EMBOLISM 13 0.0001
832 LABORATORY TEST ABNORMAL 4 0.0001
833 CARDIOMYOPATHY 2 0.0001
834 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
835 COLON CANCER 2 0.0001
836 APHASIA 4 0.0001
837 STOMATITIS 8 0.0001
838 PRODUCT AVAILABILITY ISSUE 3 0.0001
839 SYNCOPE 13 0.0001
840 PERICARDIAL EFFUSION 3 0.0001
841 FEMUR FRACTURE 4 0.0001
842 RENAL DISORDER 6 0.0001
843 BASAL CELL CARCINOMA 2 0.0001
844 SWOLLEN TONGUE 4 0.0001
845 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
846 MEDICATION ERROR 7 0.0001
847 OSTEOPOROSIS 5 0.0001
848 LIP SWELLING 4 0.0001
849 SKIN EXFOLIATION 10 0.0001
850 DISEASE PROGRESSION 14 0.0001
851 CARDIOVASCULAR DISORDER 3 0.0001
852 CIRCULATORY COLLAPSE 2 0.0001
853 HOSPITALISATION 18 0.0001
854 RESPIRATORY TRACT INFECTION 3 0.0001
855 VOMITING 54 0.0001
856 MUSCULOSKELETAL STIFFNESS 10 0.0001
857 COVID-19 20 0.0001
858 HYPERSENSITIVITY 21 0.0001
859 DYSPNOEA 64 0.0001
860 EAR INFECTION 3 0.0001
861 EXPOSURE DURING PREGNANCY 7 0.0001
862 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
863 PULMONARY OEDEMA 5 0.0001
864 DISTURBANCE IN ATTENTION 6 0.0001
865 COUGH 31 0.0001
866 PERIPHERAL SWELLING 17 0.0001
867 BONE DISORDER 2 0.0001
868 PANIC ATTACK 4 0.0001
869 ACCIDENTAL OVERDOSE 4 0.0001
870 CHEST PAIN 20 0.0001
871 CHEST DISCOMFORT 11 0.0001
872 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
873 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
874 BLOOD SODIUM DECREASED 2 0.0001
875 FOOT FRACTURE 2 0.0001
876 COLORECTAL CANCER 5 0.0001
877 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
878 DYSPHONIA 6 0.0001
879 CHOKING 2 0.0001
880 NASAL CONGESTION 6 0.0001
881 LUNG DISORDER 5 0.0001
882 OVERDOSE 22 0.0001
883 BLOOD PRESSURE ABNORMAL 2 0.0001
884 BURNING SENSATION 7 0.0001
885 PREMATURE BABY 3 0.0001
886 CARDIAC FAILURE CONGESTIVE 8 0.0001
887 LACRIMATION INCREASED 3 0.0001
888 INFLUENZA 11 0.0001
889 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
890 ADVERSE EVENT 9 0.0001
891 PRURITUS 37 0.0001
892 POLLAKIURIA 4 0.0001
893 FATIGUE 73 0.0001
894 LOSS OF CONSCIOUSNESS 12 0.0001
895 MOVEMENT DISORDER 3 0.0001
896 HYPOACUSIS 4 0.0001
897 AMNESIA 6 0.0001
898 VAGINAL HAEMORRHAGE 4 0.0001
899 TREATMENT NONCOMPLIANCE 5 0.0001
900 HEART RATE INCREASED 9 0.0001
901 ARTHROPATHY 5 0.0001
902 SKIN DISORDER 3 0.0001
903 NECK PAIN 5 0.0001
904 THROAT IRRITATION 4 0.0001
905 ARTHRITIS 7 0.0001
906 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
907 EYE PAIN 5 0.0001
908 MUSCLE SPASMS 16 0.0001
909 NEOPLASM PROGRESSION 3 0.0001
910 BACK PAIN 20 0.0001
911 SWELLING 8 0.0001
912 OCULAR HYPERAEMIA 4 0.0001
913 GAIT DISTURBANCE 16 0.0001
914 ABDOMINAL DISCOMFORT 14 0.0001
915 BLOOD GLUCOSE DECREASED 4 0.0001
916 INTERSTITIAL LUNG DISEASE 4 0.0001
917 EMOTIONAL DISTRESS 10 0.0001
918 INSOMNIA 22 0.0001
919 ABDOMINAL PAIN UPPER 17 0.0001
920 DISCOMFORT 5 0.0001
921 CEREBRAL INFARCTION 2 0.0001
922 DYSGEUSIA 6 0.0001
923 EYE SWELLING 3 0.0001
924 VISION BLURRED 11 0.0001
925 DYSPNOEA EXERTIONAL 3 0.0001
926 FLUID RETENTION 4 0.0001
927 HYPERHIDROSIS 10 0.0001
928 DIPLOPIA 2 0.0001
929 PARAESTHESIA 12 0.0001
930 WEIGHT INCREASED 17 0.0001
931 ABNORMAL BEHAVIOUR 3 0.0001
932 PAIN IN EXTREMITY 22 0.0001
933 THROMBOSIS 6 0.0001
934 FEAR 2 0.0001
935 HYPOAESTHESIA 11 0.0001
936 ABNORMAL DREAMS 2 0.0001
937 DIZZINESS 36 0.0001
938 FEELING COLD 2 0.0001
939 SLEEP DISORDER 5 0.0001
940 DEATH 61 0.0001
941 NASOPHARYNGITIS 13 0.0001
942 DRUG WITHDRAWAL SYNDROME 6 0.0001
943 BONE PAIN 4 0.0001
944 LIVER DISORDER 3 0.0001
945 IRRITABILITY 4 0.0001
946 UNEVALUABLE EVENT 5 0.0001
947 BLOOD PRESSURE INCREASED 10 0.0001
948 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
949 ANXIETY 18 0.0001
950 EYE PRURITUS 2 0.0001
951 ECZEMA 3 0.0001
952 THERAPY INTERRUPTED 4 0.0001
953 ADVERSE DRUG REACTION 5 0.0001
954 UNDERDOSE 4 0.0001
955 OROPHARYNGEAL PAIN 5 0.0001
956 DEPRESSION 12 0.0001
957 INCORRECT DOSE ADMINISTERED 12 0.0001
958 DIABETES MELLITUS 4 0.0001
959 EYE IRRITATION 3 0.0001
960 CONTUSION 5 0.0001
961 ALOPECIA 10 0.0001
962 WHEEZING 3 0.0001
963 THERAPEUTIC RESPONSE DECREASED 3 0.0000
964 DEVICE BREAKAGE 2 0.0000
965 INFLUENZA LIKE ILLNESS 4 0.0000
966 ILLNESS 5 0.0000
967 ARTHRALGIA 20 0.0000
968 DEVICE LEAKAGE 2 0.0000
969 MEMORY IMPAIRMENT 6 0.0000
970 MIGRAINE 4 0.0000
971 SKIN BURNING SENSATION 3 0.0000
972 PRODUCT DOSE OMISSION ISSUE 12 0.0000
973 ACNE 3 0.0000
974 FLUSHING 4 0.0000
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
976 DERMATITIS ATOPIC 2 0.0000
977 INJECTION SITE HAEMORRHAGE 3 0.0000
978 FEELING ABNORMAL 9 0.0000
979 PALPITATIONS 4 0.0000
980 CATARACT 2 0.0000
981 NO ADVERSE EVENT 6 0.0000
982 FEELING HOT 2 0.0000
983 CARDIAC DISORDER 3 0.0000
984 INJECTION SITE PAIN 9 0.0000
985 DEVICE MALFUNCTION 2 0.0000
986 BLOOD GLUCOSE INCREASED 5 0.0000
987 DRUG DEPENDENCE 4 0.0000
988 JOINT SWELLING 3 0.0000
989 CEREBROVASCULAR ACCIDENT 3 0.0000
990 ASTHMA 2 0.0000
991 DRY SKIN 2 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
993 DRUG DOSE OMISSION 2 0.0000